Diabetes

April 30, 2019

A sweet way to say no to Diabetes-too good to be true: Palatinose-based regenerative therapy for reversing diabetes: Isomaltulose(also known as Palatinose), an artificial sweetener consisting of  glucose and fructose,  increases the expression of Sox17, Sox2, Pdx-1, and Ngn3, decreases mTOR expression, promotes regeneration of insulin-producing ß cells, increases insulin secretion, promotes glucose homeostasis and reverses T1D and T2D via down regulation of its target gene, 1/May/2018, 12.05 am

Introduction: What they say A study from the Longevity Institute, School of Gerontology, Department of Biological Sciences, University of Southern California, 3715 McClintock Avenue, Los Angeles, […]
April 27, 2019

Ghrelin-based therapy for body weight control, energy homeostasis and TIIDM: Ghrelin  decreases CADM1 and its downstream target genes that inhibit glucose-induced insulin secretion, improves insulin sensitivity, increases energy utilization, promotes weight loss and protects from diet-induced obesity and TIIDM, via up-regulation of its target gene, 27/April/2019, 3.57pm

Introduction: What they say  A study from the Max Delbrück Center for Molecular Medicine, Berlin, Germany shows that “Regulation of body weight and energy homeostasis by […]
April 26, 2019

Molecular therapy for body weight control, energy homeostasis and TIIDM: Piromelatine,  a melatonin receptor agonist, inhibits DNA methyltransferase 3a (Dnmt3a) expression, increases FGF21 expression, augments insulin sensitivity, increases glucose tolerance, and protects from diet-induced obesity and TIIDM, via up-regulation of its target gene, 26/April/2019, 11.19 pm

Introduction: What they say  A study from Nutritional Sciences and Toxicology Department, University of California, Berkeley, Berkeley, United States shows that “Dnmt3a is an epigenetic mediator […]
April 26, 2019

Cyclin helix B peptide (CHBP)-based therapy for body weight control, energy homeostasis and TIIDM: Cyclin helix B peptide (CHBP),  derived from Erythropoietin (EPO)/Hematopoietin, inhibits DNA methyltransferase 3a (Dnmt3a) expression, increases FGF21 expression, augments insulin sensitivity, increases glucose tolerance, and protects from diet-induced obesity and TIIDM, via up-regulation of its target gene, 26/April/2019, 10.55 pm

Introduction: What they say  A study from Nutritional Sciences and Toxicology Department, University of California, Berkeley, Berkeley, United States shows that “Dnmt3a is an epigenetic mediator […]